Swisscom-backed medicine analytics platform Sophia Genetics has secured new funding, taking its overall equity capital to more than $31m.
Sophia Genetics, a Switzerland-based data-driven medicine provider backed by telecommunications firm Swisscom, closed a $15m series C round on Wednesday led by private investor Marc Coucke.
Founded in 2011 as a spinout of Federal Institute of Technology Lausanne, Sophia produces technology that diagnoses inherited diseases and analyses the DNA of tumours through a combination of next generation sequencing and machine learning algorithms.
Sophia has signed up more than 100 healthcare institutions across 20 countries to the platform, including Oxford University…
